A Phase 1 Study of LY3009120, a Pan-RAF Inhibitor, in...

Main
2019 / 10
A Phase 1 Study of LY3009120, a Pan-RAF Inhibitor, in...

Molecular Cancer Therapeutics 2019 / 10

A Phase 1 Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

Sullivan, Ryan J., Hollebecque, Antoine, Flaherty, Keith T, Shapiro, Geoffrey I., Rodon Ahnert, Jordi, Millward, Michael J., Zhang, Wei, Gao, Ling, Sykes, Amanda, Willard, Melinda D, Yu, Danni, Schade

How much do you like this book?

What’s the quality of the file?

Download the book for quality assessment

What’s the quality of the downloaded files?

Language:

english

Journal:

Molecular Cancer Therapeutics

DOI:

10.1158/1535-7163.MCT-19-0681

Date:

October, 2019

File:

PDF, 1.94 MB

english, 2019

Conversion to is in progress

Conversion to is failed